On Tuesday, Oncolytics Biotech, Inc (NASDAQ: ONCY) was -5.83% drop from the session before settling in for the closing price of $1.2. A 52-week range for ONCY has been $0.33 – $1.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 23.13% over the last five years. When this article was written, the company’s average yearly earnings per share was at 3.87%. With a float of $93.51 million, this company’s outstanding shares have now reached $96.60 million.
The firm has a total of 28 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Oncolytics Biotech, Inc (ONCY) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Oncolytics Biotech, Inc stocks. The insider ownership of Oncolytics Biotech, Inc is 3.20%, while institutional ownership is 9.89%.
Oncolytics Biotech, Inc (ONCY) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 3.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.78% during the next five years compared to 23.13% growth over the previous five years of trading.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Trading Performance Indicators
You can see what Oncolytics Biotech, Inc (ONCY) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Oncolytics Biotech, Inc (ONCY)
Analysing the last 5-days average volume posted by the [Oncolytics Biotech, Inc, ONCY], we can find that recorded value of 1.34 million was better than the volume posted last year of 1.0 million. As of the previous 9 days, the stock’s Stochastic %D was 76.67%.
During the past 100 days, Oncolytics Biotech, Inc’s (ONCY) raw stochastic average was set at 81.71%, which indicates a significant increase from 72.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1223 in the past 14 days, which was higher than the 0.0580 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6242, while its 200-day Moving Average is $0.7871. Now, the first resistance to watch is $1.1833. This is followed by the second major resistance level at $1.2367. The third major resistance level sits at $1.2733. If the price goes on to break the first support level at $1.0933, it is likely to go to the next support level at $1.0567. Now, if the price goes above the second support level, the third support stands at $1.0033.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Key Stats
There are 94,284K outstanding shares of the company, which has a market capitalization of 109.16 million. As of now, sales total 0 K while income totals -23,140 K. Its latest quarter income was 0 K while its last quarter net income were -4,660 K.